Working Group 3: Automating release

WORKING GROUP 3
*CLOSED FOR APPLICATIONS*

Automating release for autologous products

Topics covered: In absence of tailored solutions for automating QC and release, what are we doing with the technology that we've got? How can I use automation to limit variabilily? Looking at common assays across advanced therapies and what opportunities does automation hold for those? Fill and finish automation. The long-term direction of travel is to eliminate QC facilities - what is on the wishlist of solutions to make this a reality? 

Outcome: Publish a collection of recommendations for industrialising QC for autologous products in today's environment. En route to the goal of industrialising production of autologous therapeutics, what practical solutions are being implemented today?

Who should attend?
  • Autologous biotechs of all clinical stages, with a challenging release process, that are looking towards automation to limit variability, ideally with experience building custom solutions or repurposing existing technology to scale up
  • Engineering firms working with biotech on in-line analytics
  • CMOs
  • Vendors in this space 
Dates & times to note

June 23rd 2021
Meeting: 2pm – 3:30pm BST
Feedback Loop and Networking (optional): 4pm – 5pm BST

September 22nd 2021
Meeting: 2pm – 3:30pm BST
Feedback Loop and Networking (optional): 4pm – 5pm BST

December 15th 2021
Meeting: 2pm – 3:30pm GMT
Feedback Loop and Networking (optional): 4pm – 5pm GMT

March 22nd 2022
Meeting: 2pm – 3:30pm GMT
Feedback Loop and Networking (optional): 4pm – 5pm GMT
This working group is sponsored by
THIS WORKING GROUP IS NOW CLOSED FOR APPLICATIONS